Biontech Se Sponsored Adr Stock News

Black Friday Turns Red On "Terrible News" - Global Markets Crater On "Nu Variant" Panic The Friday after thanksgiving is called black Friday because that''s when retailers finally turn profitable for the year. Not so much for market, however, because this morning it''s red as far as the eye can see. The culprit: the same one we discussed late last night - the emergence of a new coronavirus strain detected in South Africa, known as B.1.1.529, which reportedly carries an "extremely high number" of mutations and is “clearly very different” from previous incarnations, which may drive further waves of disease by evading the body’s defenses according to South African scientists, and soon, Anthony Fauci. British authorities think it is the most significant variant to date and have hurried to impose travel restrictions on southern Africa, as did Japan, the Czech Republic and Italy on Friday. The European Union also said it aimed to halt air travel from the region. "Markets have been quite complacent about the pandemic for a while, partly because economies have been able to withstand the impact of selective lockdown measures.

Dr. Scott Gottlieb, former FDA commissioner, joins 'Closing Bell' to discuss the new Covid-19 variant. He says if the majority of the population is vaccinated it can be effective in protecting people

Pfizer and BioNTech said they expect more data from lab tests in two weeks at the latest.

Wall Street Tumbles on Resurgence of Coronavirus.

Little is known about the new COVID strain emerging in Africa. That hasn't stopped traders from betting big on lockdowns and a return to telework.

The stock prices of vaccine makers Moderna and Pfizer surged Friday along with stay-at-home stocks like Zoom Video and Peloton.

The B.1.1.529 variant has been detected in South Africa, Botswana, Hong Kong, and Israel, and is spreading rapidly.

Pfizer (PFE)/BioNTech (BNTX) COVID-19 vaccine, Comirnaty, if approved for use in children aged five to 11, will be the first vaccine to be approved for administration in this age group in Europe

The stock price of BioNTech SE (NASDAQ: BNTX) increased by over 7% pre-market today. This is why it happened.

The European Medicines Agency's (EMA) human medicines committee (CHMP) recommended using Pfizer Inc (NYSE: PFE) - BioNTech SE's (NASDAQ: BNTX)'s COVID-19 vaccine, Comirnaty, for children between

EMAs human medicines committee (CHMP) and its experts have been working intensively over the past weeks to evaluate data submitted by BioNTech and

EMA has received an application for conditional marketing authorisation (CMA) for BNT162b2, a COVID19 mRNA vaccine developed by BioNTech and Pfizer. The

Pfizer and BioNTech have said their vaccine, Comirnaty, showed 90.7% efficacy against the coronavirus in a clinical trial of children aged 5 to 11.

The Commission for Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EDA) has recommended that the use of the Comirnaty vaccine by Biontech / Pfizer against COVID-19 be given to children aged 5 to 11 years. The vaccine is already used on children that are 12 years old. For the new group, however, the dose will be 10 milligrams, while for the rest it is 30 milligrams. It will also be injected twice into the upper arm of the patient over a period of three weeks. Study: COVID Protection Weakens Gradually after Second Dose of the Pfizer Vaccine The recommendation was announced after studies in children between the ages of 5 and 11. The immune response to the injection of 10 milligrams of Comirnaty in this age group was comparable to that of 30 grams given to people aged 16 to 25 years. The effectiveness of Comirnaty has been estimated in almost 2,000 children aged 5 to 11. They have been vaccinated or given a placebo. Of the 1,305 children vaccinated with the drug, only three got infected with COVID-19.

NEW YORK and MAINZ, Germany, November 25, 2021-Pfizer Inc.(Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency